Adane B, Ye H, Khan N, Pei S, Minhajuddin M, Stevens BM, Jones CL, D’Alessandro A, Reisz JA, Zaberezhnyy V (2019) The hematopoietic oxidase NOX2 regulates self-renewal of leukemic stem cells. Cell Rep 27:238–254
CAS
Article
Google Scholar
Altenhöfer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans J, Schiffers P, Ho H, Wingler K, Schmidt HH (2012) The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 69:2327–2343
Article
Google Scholar
Altenhöfer S, Radermacher KA, Kleikers PW, Wingler K, Schmidt HH (2015) Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal 23:406–427
Article
Google Scholar
Anilkumar N, Weber R, Zhang M, Brewer A, Shah AM (2008) Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler Thromb Vasc Biol 28:1347–1354
CAS
Article
Google Scholar
Augsburger F, Filippova A, Rasti D, Seredenina T, Lam M, Maghzal G, Mahiout Z, Jansen-Dürr P, Knaus UG, Doroshow J (2019) Pharmacological characterization of the seven human NOX isoforms and their inhibitors. Redox Biol 26:101272
CAS
Article
Google Scholar
Chan SM, Majeti R (2013) Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia. Int J Hematol 98:648–657
CAS
Article
Google Scholar
Cucchi DG, Polak TB, Ossenkoppele GJ, Groot UD, Carin A, Cloos J, Zweegman S, Janssen JJ (2021) Two decades of targeted therapies in acute myeloid leukemia. Leukemia 35:651–660
Article
Google Scholar
Dao VT-V, Elbatreek MH, Altenhöfer S, Casas AI, Pachado MP, Neullens CT, Knaus UG, Schmidt HH (2020) Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation. Free Radical Biol Med 148:60–69
CAS
Article
Google Scholar
Heidel F, Solem FK, Breitenbuecher F, Lipka DB, Kasper S, Thiede M, Brandts C, Serve H, Roesel J, Giles F (2006) Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain. Blood 107:293–300
CAS
Article
Google Scholar
Heidel FH, Bullinger L, Feng Z, Wang Z, Neff TA, Stein L, Kalaitzidis D, Lane SW, Armstrong SA (2012) Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML. Cell Stem Cell 10:412–424
CAS
Article
Google Scholar
Heidel FH, Bullinger L, Arreba-Tutusaus P, Wang Z, Gaebel J, Hirt C, Niederwieser D, Lane SW, Döhner K, Vasioukhin V (2013) The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML. J Exp Med 210:15–22
CAS
Article
Google Scholar
Helfinger V, Von Gall FF, Henke N, Kunze MM, Schmid T, Rezende F, Heidler J, Wittig I, Radeke HH, Marschall V (2021) Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors. Proc Natl Acad Sci 118
Jayavelu A, Müller J, Bauer R, Böhmer S, Lässig J, Cerny-Reiterer S, Sperr W, Valent P, Maurer B, Moriggl R (2016) NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells. Leukemia 30:473–483
CAS
Article
Google Scholar
Jayavelu AK, Schnoder TM, Perner F, Herzog C, Meiler A, Krishnamoorthy G, Huber N, Mohr J, Edelmann-Stephan B, Austin R et al (2020) Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms. Nature 588:157–163
Article
Google Scholar
Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, Garcia-Manero G, Konopleva M, Ravandi F (2021) Acute myeloid leukemia: current progress and future directions. Blood Cancer J 11:1–25
Article
Google Scholar
Lee BH, Tothova Z, Levine RL, Anderson K, Buza-Vidas N, Cullen DE, McDowell EP, Adelsperger J, Fröhling S, Huntly BJ (2007) FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 12:367–380
CAS
Article
Google Scholar
Li L, Piloto O, Nguyen HB, Greenberg K, Takamiya K, Racke F, Huso D, Small D (2008) Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model. Blood J Am Soc Hematol 111:3849–3858
CAS
Google Scholar
Meitzler JL, Makhlouf HR, Antony S, Wu Y, Butcher D, Jiang G, Juhasz A, Lu J, Dahan I, Jansen-Dürr P (2017) Decoding NADPH oxidase 4 expression in human tumors. Redox Biol 13:182–195
CAS
Article
Google Scholar
Mohr J, Dash BP, Schnoeder TM, Wolleschak D, Herzog C, Tubio Santamaria N, Weinert S, Godavarthy S, Zanetti C, Naumann M (2018) The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell function. Leukemia 32:1211–1221
CAS
Article
Google Scholar
Naughton R, Quiney C, Turner S, Cotter T (2009) Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway. Leukemia 23:1432–1440
CAS
Article
Google Scholar
Perner F, Schnoeder TM, Xiong Y, Jayavelu AK, Mashamba N, Santamaria NT, Huber N, Todorova K, Hatton C, Perner B (2021) YBX1 mediates translation of oncogenic transcripts to control cell competition in AML. Leukemia 1–12
Prieto-Bermejo R, Romo-González M, Pérez-Fernández A, García-Tuñón I, Sánchez-Martín M, Hernández-Hernández Á (2021) Cyba-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins. Haematologica 106:142
CAS
Article
Google Scholar
Purton LE, Scadden DT (2007) Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell 1:263–270
CAS
Article
Google Scholar
Reddy MM, Fernandes MS, Salgia R, Levine RL, Griffin JD, Sattler M (2011) NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases. Leukemia 25:281–289
CAS
Article
Google Scholar
Schnöder T, Arreba-Tutusaus P, Griehl I, Bullinger L, Buschbeck M, Lane S, Döhner K, Plass C, Lipka D, Heidel F (2015) Epo-induced erythroid maturation is dependent on Plcγ1 signaling. Cell Death Differ 22:974–985
Article
Google Scholar
Schnoeder TM, Schwarzer A, Jayavelu AK, Hsu C-J, Kirkpatrick J, Döhner K, Perner F, Eifert T, Huber N, Arreba-Tutusaus P (2022) PLCG1 is required for AML1-ETO leukemia stem cell self-renewal. Blood J Am Soc Hematol 139:1080–1097
CAS
Google Scholar
Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N (2012) Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110:1217–1225
Article
Google Scholar
Stanicka J, Russell EG, Woolley JF, Cotter TG (2015) NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells. J Biol Chem 290:9348–9361
CAS
Article
Google Scholar
Tarafdar A, Pula G (2018) The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. Int J Mol Sci 19:3824
Article
Google Scholar
Uckelmann HJ, Kim SM, Antonissen NJ, Krivtsov AV, Hatton C, McGeehan GM, Levine RL, Vassiliou GS, Armstrong SA (2018) MLL-Menin inhibition reverses pre-leukemic progenitor self-renewal induced by NPM1 mutations and prevents AML development. Blood 132:546
Article
Google Scholar